Beckman Coulter feto-maternal hemorrhage, sepsis and infection tests

Wednesday, 24 November, 2010 | Supplied by: Beckman Coulter Australia



Beckman Coulter has entered into a strategic alliance with Trillium Diagnostics LLC, under the terms of which Beckman Coulter will market specific products in North America and South America and in the majority of Europe, Asia and Australasia.

Trillium Diagnostics products covered in this agreement include assays for feto-maternal hemorrhage testing (FETALtrol control) and cellular HbF level quantitation (FMH QuikQuant), as well as Leuko64, which is used for sepsis and infection detection by flow cytometry.

Adding these products to the Beckman Coulter line for flow cytometry will enable the company to provide diagnostic laboratories and research institutes with targeted flow cytometry products that address specific, unmet medical needs.

Online: www.beckman.com.au
Phone: 1800 060 878
Related Products

Tecan Crescendo cDNA Synthesis for qPCR kit

Tecan has launched the Crescendo cDNA Synthesis for qPCR system to provide increased sensitivity...

Lonza HLA-typed cells

Lonza now provides an expansive selection of high-resolution human leukocyte antigen (HLA)-typed...

Bio-Rad Laboratories StarBright dyes for flow cytometry

StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 are fluorescent...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd